Where there's a WiL, there's a way
An international alliance dedicated to the promotion of
leadership of female lymphoma clinicians, researchers and educators
“WiL is committed to supporting and advocating for greater leadership of women in lymphoma globally”
We advocate for and promote equal representation at conferences, on panels, leadership committees and in research and we promote opportunities for WiL globally and celebrate the successes of our members.
We encourage networking, and engagement for WiL through dedicated meetings at major conferences and information sharing via our newsletters, webinars and website.
We facilitate education of WiL through our dedicated webinar lecture series and events run by our internationally renowned WiL members as well as promote activities run by our members.
Mentoring and role models are essential in every career path. Many of us have female trainees keen to lead research/clinical service/teaching programmes and seeing other women in these roles has inspired them to follow a similar path.
It is essential for all our junior lymphoma colleagues to see women in leadership roles within lymphoma. This not only helps the “you cannot be what you cannot see” hurdle but also leads to productive diversity on decision making boards.
A key focus of Women in Lymphoma (WiL) is to mentor other women, encouraging them to put themselves forward for career progression opportunities. By highlighting other women’s achievements through WiLing Wednesdays - a high-level education programme - it allows identification of clear role models and mentors. Through this popular educational series across lymphoma histologies, we hope to show that these leading WiL are not exceptional but should be the norm.
Nonetheless, the majority of lymphoma leaders internationally are male and mentorship is not a gender-restricted exercise. Emerging women need male mentors too, and senior women in lymphoma seek to mentor young men as well as women.
In 2021, Women in Lymphoma will be encouraging the involvement of leading men in lymphoma, as champions of change, to work with WiL on initiatives to identify and reduce barriers which may prevent women choosing or being for a leadership path in lymphoma.
With the enabling support of Lymphoma Australia www.lymphoma.org.au Women in Lymphoma seeks to harness the potential of all emerging lymphoma leaders - both male and female - for the improvement of lymphoma research and patient care.
Series 7 – THEME: LYMPHOMA & THE BRAIN
SEPTEMBER 21 & 28, OCTOBER 5, 12 & 19, 2022
· Join WiL around the world in our 7th live and free educational webinar series
with leading and emerging WiL presenting and discussing challenging aspects
of contemporary management of lymphoma.
· Free sessions on Zoom open to all clinicians, researchers and educators
in lymphoma, industry and associated fields.
· Registration for each session via registration links below
or please contact firstname.lastname@example.org for more details.
· Session times shown in local time of presenters
and for you in your local time after registration.
UTC = Universal Time Coordinated. www.timeanddate.com
· All five sessions will be recorded and links posted below after each session.
* * * *
SESSION 1 - Wednesday, September 21, 2022
PCSNL - Diagnosis and Treatment RECORDING LINK:
SESSION 2 - Wednesday, September 28, 2022
PSNSL - Elderly and side effects RECORDING LINK:
SESSION 3 - Wednesday, October 5, 2022
8pm - 9pm CEST
SCNSL and CAR-T RECORDING LINK:
SESSION 4 - Wednesday, October 12, 2022
8pm - 9pm CEST
Debate on CNS Prophylaxis REGISTRATION LINK:
SESSION 5 - Wednesday, October 19
8pm - 9pm CEST
Other brain lymphomas and PVRL REGISTRATION LINK:
* * * * *
Kat grew up and completed the majority of her medical and haematology training in the UK, before relocating to Australia to complete her specialist training as a Clinical Research and Lymphoma Fellow in 2018. She has an interest in lymphoma and is working in Sir Charles Gairdner Hospital and Linear Clinical Research in Perth, Western Australia. She has extensive experience as a sub investigator on a large number of clinical trials, with a focus on lymphoma and CLL, and recently began to gain experience as a clinical trial principal investigator.
She is active in investigator initiated research and has led and collaborated on several retrospective clinical studies, including a large international study investigating the effectiveness of systemic methotrexate in preventing CNS relapse in aggressive B-cell lymphoma, for which she was awarded the ASH-HSANZ Outstanding Abstract award in 2021. She has recently been appointed as the inaugural Early Career Clinician Researcher in the Australasian Leukaemia and Lymphoma Group (ALLG). Outside of her work as a haematologist, Kat is a wife, mum of two young girls and enjoys running.